A Phase IIb/III, Multi-Center, Randomized, Parallel Group, Controlled Study to Evaluate the Efficacy and Safety of 750 mg and 1000 mg of LLL-3348 of Lupin Limited in Moderate to Severe Chronic Stable Plaque Type of Psoriasis.
Phase of Trial: Phase II/III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs LLL 3348 (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Lupin
- 11 Dec 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 28 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 09 Feb 2010 New trial record